{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T01:58:21Z","timestamp":1789869501675,"version":"4.0.1"},"reference-count":27,"publisher":"Wiley","issue":"S1","license":[{"start":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T00:00:00Z","timestamp":1525824000000},"content-version":"vor","delay-in-days":8,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Lab Hematology"],"published-print":{"date-parts":[[2018,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Introduction<\/jats:title><jats:p>Congenital Erythrocytosis (<jats:styled-content style=\"fixed-case\">CE<\/jats:styled-content>) represents a rare and heterogeneous clinical entity. It is caused by deregulated erythropoiesis where red blood cell overproduction results in elevated hemoglobin and hematocrit levels. <jats:styled-content style=\"fixed-case\">CE<\/jats:styled-content> may either be primary or secondary to elevated erythropoietin concentrations. The only known form of primary <jats:styled-content style=\"fixed-case\">CE<\/jats:styled-content> is caused by mutations in the <jats:styled-content style=\"fixed-case\">EPOR<\/jats:styled-content> gene. Secondary <jats:styled-content style=\"fixed-case\">CE<\/jats:styled-content> can be a consequence of tissue hypoxia, being caused by congenital defects such as hemoglobin variants with increased oxygen affinity, due to mutations in the \u03b1\u2010 or \u03b2\u2010globin genes (<jats:styled-content style=\"fixed-case\">HBB<\/jats:styled-content>,<jats:styled-content style=\"fixed-case\"> HBA<\/jats:styled-content>2, <jats:styled-content style=\"fixed-case\">HBA<\/jats:styled-content>1), or due to mutations in the <jats:styled-content style=\"fixed-case\">BPGM<\/jats:styled-content> gene. Secondary <jats:styled-content style=\"fixed-case\">CE<\/jats:styled-content> can also result from defects in the components of the oxygen\u2010sensing pathway (<jats:styled-content style=\"fixed-case\">PHD<\/jats:styled-content>2, <jats:styled-content style=\"fixed-case\">HIF<\/jats:styled-content>2\u03b1 and <jats:styled-content style=\"fixed-case\">VHL<\/jats:styled-content>).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methodology<\/jats:title><jats:p>The family history and the quantification of serum <jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content> are mandatory to define the best diagnostic strategy regarding molecular studies. Based upon the serum <jats:styled-content style=\"fixed-case\">EPO<\/jats:styled-content> level, P50 and familial data, it is possible to establish a diagnostic algorithm.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Despite recent important discoveries in the molecular pathogenesis of <jats:styled-content style=\"fixed-case\">CE<\/jats:styled-content>, in about 70% of the patients the genetic causes remain to be identified. Clinical data on patients suffering from <jats:styled-content style=\"fixed-case\">CE<\/jats:styled-content> are sparse. This fact is conditional upon the effective way to predict the disease evolution, the establishment of the best management and the genetic counselling.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The number and phenotypic variability of patients that remain without an identified etiology suggest that other genes have to be implicated. Studies by next generation sequencing methodologies are already being performed and it is expected the identification of other genes involved in the pathophysiology of the <jats:styled-content style=\"fixed-case\">CE<\/jats:styled-content>.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ijlh.12828","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T10:59:00Z","timestamp":1525863540000},"page":"62-67","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":43,"title":["Genetic basis of congenital erythrocytosis"],"prefix":"10.1111","volume":"40","author":[{"given":"C.","family":"Bento","sequence":"first","affiliation":[{"name":"Department of Hematology Centro Hospitalar e Universit\u00e1rio de Coimbra  Coimbra Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,5,9]]},"reference":[{"key":"e_1_2_7_2_1","first-page":"44","volume-title":"De l'anemie des altitudes et de l'anemie in general dans ses raports avec la pression del l\u2019 atmosphere","author":"Jourdanet D","year":"1863"},{"key":"e_1_2_7_3_1","first-page":"384","article-title":"Sur l'activit\u00e9 h\u00e9motpoietique du s\u00e9rum au ours de la regeneration du sang","volume":"143","author":"Carnot P","year":"1906","journal-title":"Comptes Rendus de l'Acad\u00e9mie des Sciences"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/00062752-199603020-00009"},{"key":"e_1_2_7_5_1","first-page":"447","article-title":"A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation","volume":"125","author":"Semenza G","year":"1992","journal-title":"Mol Cell Biol"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.7604250"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1097\/00008480-200002000-00006"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)71142-9"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa065202"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2011.1.208"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2009.08069.x"},{"key":"e_1_2_7_12_1","first-page":"1495","volume-title":"Wintrobe's Clinical Hematology","author":"Means RT","year":"2004"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/humu.22448"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.10.4495"},{"key":"e_1_2_7_15_1","first-page":"1993","volume-title":"GeneReviews\u00ae","author":"Bento C","year":"2016"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng1019"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2550"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2003-07-2535"},{"key":"e_1_2_7_19_1","first-page":"413","article-title":"The incidence of the JAK2V617F mutation in patients with idiopathic erythrocytosis","volume":"91","author":"Percy M","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI105397"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a011858"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.3109\/03630260009002275"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1172\/JCI109218"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2014.109306"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1751-553X.2008.01102.x"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24625"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.144063"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3304"}],"container-title":["International Journal of Laboratory Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fijlh.12828","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.12828","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,13]],"date-time":"2023-09-13T19:39:22Z","timestamp":1694633962000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijlh.12828"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":27,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["10.1111\/ijlh.12828"],"URL":"https:\/\/doi.org\/10.1111\/ijlh.12828","archive":["Portico"],"relation":{},"ISSN":["1751-5521","1751-553X"],"issn-type":[{"value":"1751-5521","type":"print"},{"value":"1751-553X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"2018-01-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-03-19","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-05-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}